The Regional Medicines Optimisation Committee (RMOC, Midlands and East) has reviewed issues around the prescribing and commissioning of sodium oxybate in adult patients with narcolepsy with cataplexy.

The document aims to facilitate local decisions by a CCG on whether to commission sodium oxybate for use in all adult patients. It suggests a framework by which a CCG can ensure that sodium oxybate is used appropriately and safely under the strict criteria set out within this statement. This statement does not stipulate that sodium oxybate must be commissioned, but aims to assist this decision making process and improve consistency.

Attachments

• Sodium Oxybate Advisory Statement · Word · 125 KB